Clinical Trial Update: A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy [Phase 2]

View source ↗

Summary

This Phase II trial of PG2 in patients with advanced pharyngeal or laryngeal squamous cell carcinoma undergoing concurrent chemoradiotherapy has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Fatigue
• Laryngeal Squamous Cell Carcinoma
• Pharyngeal Squamous Cell Carcinoma

Drugs mentioned

• PG2

Snippet

Sponsor: PhytoHealth Corporation | Conditions: Cancer-related Fatigue | Phase 2 | Status: TERMINATED